117 related articles for article (PubMed ID: 22178720)
1. An indirubin derivative, E804, exhibits potent angiosuppressive activity.
Chan YK; Kwok HH; Chan LS; Leung KS; Shi J; Mak NK; Wong RN; Yue PY
Biochem Pharmacol; 2012 Mar; 83(5):598-607. PubMed ID: 22178720
[TBL] [Abstract][Full Text] [Related]
2. Indirubin derivative E804 inhibits angiogenesis.
Shin EK; Kim JK
BMC Cancer; 2012 May; 12():164. PubMed ID: 22554053
[TBL] [Abstract][Full Text] [Related]
3. Modulation of glioma-inflammation crosstalk profiles in human glioblastoma cells by indirubin-3'-(2,3 dihydroxypropyl)-oximether (E804) and 7-bromoindirubin-3'-oxime (7BIO).
Scobie MR; Houke HR; Rice CD
Chem Biol Interact; 2019 Oct; 312():108816. PubMed ID: 31505164
[TBL] [Abstract][Full Text] [Related]
4. Indirubin-3'-(2,3 dihydroxypropyl)-oximether (E804) is a potent modulator of LPS-stimulated macrophage functions.
Babcock AS; Anderson AL; Rice CD
Toxicol Appl Pharmacol; 2013 Jan; 266(1):157-66. PubMed ID: 23107598
[TBL] [Abstract][Full Text] [Related]
5. The angiosuppressive effects of 20(R)- ginsenoside Rg3.
Yue PY; Wong DY; Wu PK; Leung PY; Mak NK; Yeung HW; Liu L; Cai Z; Jiang ZH; Fan TP; Wong RN
Biochem Pharmacol; 2006 Aug; 72(4):437-45. PubMed ID: 16793023
[TBL] [Abstract][Full Text] [Related]
6. Anti-angiogenic activity and mechanism of kaurane diterpenoids from Wedelia chinensis.
Huang W; Liang Y; Wang J; Li G; Wang G; Li Y; Chung HY
Phytomedicine; 2016 Mar; 23(3):283-92. PubMed ID: 26969382
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of angiogenic attributes by decursin in endothelial cells and ex vivo rat aortic ring angiogenesis model.
Bhat TA; Moon JS; Lee S; Yim D; Singh RP
Indian J Exp Biol; 2011 Nov; 49(11):848-56. PubMed ID: 22126016
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of oral bioavailability of E804 by self-nanoemulsifying drug delivery system (SNEDDS) in rats.
Heshmati N; Cheng X; Eisenbrand G; Fricker G
J Pharm Sci; 2013 Oct; 102(10):3792-9. PubMed ID: 23934779
[TBL] [Abstract][Full Text] [Related]
9. Physicochemical characterization and in vitro permeation of an indirubin derivative.
Heshmati N; Wagner B; Cheng X; Scholz T; Kansy M; Eisenbrand G; Fricker G
Eur J Pharm Sci; 2013 Nov; 50(3-4):467-75. PubMed ID: 23994641
[TBL] [Abstract][Full Text] [Related]
10. A novel 2-aminobenzimidazole-based compound Jzu 17 exhibits anti-angiogenesis effects by targeting VEGFR-2 signalling.
Lien JC; Chung CL; Huang TF; Chang TC; Chen KC; Gao GY; Hsu MJ; Huang SW
Br J Pharmacol; 2019 Oct; 176(20):4034-4049. PubMed ID: 31368127
[TBL] [Abstract][Full Text] [Related]
11. AGS-30, an andrographolide derivative, suppresses tumor angiogenesis and growth in vitro and in vivo.
Li J; Li F; Tang F; Zhang J; Li R; Sheng D; Lee SM; Zhou GC; Leung GP
Biochem Pharmacol; 2020 Jan; 171():113694. PubMed ID: 31706845
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory effects of indirubin derivatives on influenza A virus-infected human pulmonary microvascular endothelial cells.
Kwok HH; Poon PY; Fok SP; Ying-Kit Yue P; Mak NK; Chan MC; Peiris JS; Wong RN
Sci Rep; 2016 Jan; 6():18941. PubMed ID: 26732368
[TBL] [Abstract][Full Text] [Related]
13. E804 induces growth arrest, differentiation and apoptosis of glioblastoma cells by blocking Stat3 signaling.
Zhang Y; Du Z; Zhuang Z; Wang Y; Wang F; Liu S; Wang H; Feng H; Li H; Wang L; Zhang X; Hao A
J Neurooncol; 2015 Nov; 125(2):265-75. PubMed ID: 26386687
[TBL] [Abstract][Full Text] [Related]
14. Coral-derived compound WA-25 inhibits angiogenesis by attenuating the VEGF/VEGFR2 signaling pathway.
Lin SW; Huang SC; Kuo HM; Chen CH; Ma YL; Chu TH; Bee YS; Wang EM; Wu CY; Sung PJ; Wen ZH; Wu DC; Sheu JH; Tai MH
Mar Drugs; 2015 Feb; 13(2):861-78. PubMed ID: 25668036
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer.
Kong D; Li Y; Wang Z; Banerjee S; Sarkar FH
Cancer Res; 2007 Apr; 67(7):3310-9. PubMed ID: 17409440
[TBL] [Abstract][Full Text] [Related]
16. A therapeutically relevant, 3,3'-diindolylmethane derivative NGD16 attenuates angiogenesis by targeting glucose regulated protein, 78kDa (GRP78).
Nayak D; Amin H; Rah B; Ur Rasool R; Sharma D; Gupta AP; Kushwaha M; Mukherjee D; Goswami A
Chem Biol Interact; 2015 May; 232():58-67. PubMed ID: 25794856
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo evaluations of the performance of an indirubin derivative, formulated in four different self-emulsifying drug delivery systems.
Heshmati N; Cheng X; Dapat E; Sassene P; Eisenbrand G; Fricker G; Müllertz A
J Pharm Pharmacol; 2014 Nov; 66(11):1567-75. PubMed ID: 24961657
[TBL] [Abstract][Full Text] [Related]
18. Paeonol exerts anti-angiogenic and anti-metastatic activities through downmodulation of Akt activation and inactivation of matrix metalloproteinases.
Kim SA; Lee HJ; Ahn KS; Lee HJ; Lee EO; Ahn KS; Choi SH; Jung SJ; Kim JY; Baek N; Kim SH
Biol Pharm Bull; 2009 Jul; 32(7):1142-7. PubMed ID: 19571375
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Developmental Toxicity Induced by E804 in Zebrafish Embryos.
Wang R; Liu K; Zhang Y; Chen X; Wang X
Front Pharmacol; 2020; 11():32. PubMed ID: 32116709
[TBL] [Abstract][Full Text] [Related]
20. Indirubin 3'-(O-oxiran-2-ylmethyl)oxime: a novel anticancer agent.
Ichimaru Y; Saito H; Uchiyama T; Metori K; Tabata K; Suzuki T; Miyairi S
Bioorg Med Chem Lett; 2015 Apr; 25(7):1403-6. PubMed ID: 25765906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]